- Paraneoplastic syndrome
-
Paraneoplastic syndrome Classification and external resources DiseasesDB 2064 eMedicine med/1747 MeSH D010257 A paraneoplastic syndrome is a disease or symptom that is the consequence of the presence of cancer in the body, but is not due to the local presence of cancer cells[1]. These phenomena are mediated by humoral factors (by hormones or cytokines) excreted by tumor cells or by an immune response against the tumor. Paraneoplastic syndromes are typical among middle aged to older patients, and they most commonly present with cancers of the lung, breast, ovaries or lymphatic system (a lymphoma).[2] Sometimes the symptoms of paraneoplastic syndromes show before the diagnosis of a malignancy, which has been hypothesized to relate to the disease pathogenesis. In this paradigm, tumor cells express tissue-restricted antigens (such as neuronal proteins), triggering an anti-tumor immune response which may be partially or, rarely, completely effective[3] in suppressing tumor growth and symptoms[4][5]. Patients then come to clinical attention when this tumor immune response breaks immune tolerance and begins to attack the normal tissue expressing that (e.g. neuronal) protein.
Contents
Classification
Paraneoplastic syndromes can be divided into four main categories: Endocrine, neurological, mucocutaneous and hematological paraneoplastic syndromes, as well as others that may not fit into any of the above categories:
Syndrome class Syndrome Main causal cancers Causal mechanism Endocrine[6] Cushing syndrome - small-cell lung cancer [7]
- Pancreatic carcinoma [7]
- Neural tumors [7]
- Thymoma
Ectopic ACTH and ACTH-like substance SIADH - small-cell lung cancer [7]
- CNS malignancies [7]
antidiuretic hormone [7] Hypercalcemia - Lung cancer (typically squamous cell) [7]
- Breast carcinoma [7]
- Renal carcinoma [7]
- Multiple myeloma (may occur independent of osteolytic lesions)
- Adult T cell leukemia/lymphoma [7]
- Ovarian carcinoma [7]
PTHrP (Parathyroid hormone-related protein), TGF-α, TNF, IL-1 [7] Hypoglycemia - Fibrosarcoma [7]
- Other mesenchymal sarcomas [7]
- Hepatocellular carcinoma [7]
Insulin or insulin-like substance[7] or "big" IGF-II Carcinoid syndrome Serotonin, bradykinin [7] Polycythemia See hematological paraneoplastic syndromes Neurological [8] Lambert-Eaton myasthenic syndrome (LEMS) - Small-cell lung cancer
Immunologic Paraneoplastic cerebellar degeneration - lung
- ovarian cancer
- breast carcinoma
Encephalomyelitis inflammation of the brain and spinal cord Limbic encephalitis - small-cell lung carcinoma
Brainstem encephalitis Paraneoplastic Opsoclonus (involving eye movement)-Myoclonus - breast carcinoma
- ovarian carcinoma
- small-cell lung carcinoma
- neuroblastoma (in children)
Autoimmune reaction against the RNA-binding protein Nova-1[9] Anti-NMDA receptor encephalitis Autoimmune reaction against NMDA-receptor subunits Polymyositis Mucocutaneous [11] Acanthosis nigricans Dermatomyositis Immunologic [7] Leser-Trélat sign Necrolytic migratory erythema Glucagonoma Sweet's syndrome Florid cutaneous papillomatosis Pyoderma gangrenosum Acquired generalized hypertrichosis Hematological [12] Granulocytosis G-CSF Polycythemia - Renal carcinoma [7]
- Cerebellar hemangioma [7]
- Hepatocellular carcinoma [7]
Erythropoietin [7] Trousseau sign Mucins that activate clotting[7], others Nonbacterial thrombotic endocarditis - Advanced cancers [7]
Hypercoagulability [7] Anemia - Thymic neoplasms [7]
Unknown[7] Others Membranous glomerulonephritis - Various [7]
- Tumor antigens [7]
- Immune complexes [7]
Tumor-induced osteomalacia - Hemangiopericytoma
- Phosphaturic mesenchymal tumor[13]
- FGF-23 (Fibroblast growth factor-23)
Stauffer syndrome Neurological
A particularly devastating form of paraneoplastic syndromes is a group of disorders classified as paraneoplastic neurological disorders (PNDs).[14] These paraneoplastic disorders affect the central or peripheral nervous system; some are degenerative [15], though others (such as LEMS) may improve with treatment of the condition or the tumour. Symptoms of paraneoplastic neurological disorders may include ataxia (difficulty with walking and balance), dizziness, nystagmus (rapid uncontrolled eye movements), difficulty swallowing, loss of muscle tone, loss of fine motor coordination, slurred speech, memory loss, vision problems, sleep disturbances, dementia, seizures, sensory loss in the limbs.
The most common cancers associated with paraneoplastic neurological disorders are breast, ovarian and lung cancer, but many other cancers can produce paraneoplastic symptoms as well.
Treatment options include:
- Therapies to eliminate the underlying cancer such as chemotherapy, radiation and surgery, and
- Therapies to reduce or slow neurological degeneration. Rapid diagnosis and treatment are critical for the patient to have the best chance of recovery. Since these disorders are relatively rare, few doctors have seen or treated PNDs. Therefore, it is important that PND patients consult with a specialist with experience in diagnosing and treating paraneoplastic neurological disorders.
Organizations
The International Paraneoplastic Association (IPA) is an organization dedicated to providing support and information to those affected by paraneoplastic neurological disorders.
References
- ^ Paraneoplastic Syndromes, 2011, Darnell & Posner
- ^ NINDS Paraneoplastic Syndromes Information Page National Institute of Neurological Disorders and Stroke
- ^ Darnell,R.B., DeAngelis,L.M. (1993), "Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies", Lancet 341 (8836): 21-22, PMID 8093269
- ^ Roberts,W.K., Darnell,R.B. (2004), "Neuroimmunology of the paraneoplastic neurological degenerations", Current Opinions in Immunology 16 (5): 616-622, doi:10.1016/j.coi.2004.07.009, PMID 15342008
- ^ Albert,M.A., Darnell,R.B. (2004), "Paraneoplastic neurological degenerations: keys to tumour immunity", Nature Reviews Cancer 4 (1): 36-44, PMID 14708025
- ^ MeSH Paraneoplastic+endocrine+syndromes
- ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao Table 6-5 in: Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson (2007). Robbins Basic Pathology. Philadelphia: Saunders. ISBN 1-4160-2973-7. 8th edition.
- ^ MeSH Nervous+system+paraneoplastic+syndromes
- ^ Buckanovich RJ, Posner JB, Darnell RB (1993). "Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system". Neuron 11 (4): 657–72. doi:10.1016/0896-6273(93)90077-5. PMID 8398153.
- ^ Dalmau J, Tüzün E, Wu HY et al. (January 2007). "Paraneoplastic Anti–N-methyl-D-aspartate Receptor Encephalitis Associated with Ovarian Teratoma". Ann. Neurol. 61 (1): 25–36. doi:10.1002/ana.21050. PMC 2430743. PMID 17262855. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2430743.
- ^ Cohen PR, Kurzrock R (1997). "Mucocutaneous paraneoplastic syndromes". Semin. Oncol. 24 (3): 334–59. PMID 9208889.
- ^ Staszewski H (1997). "Hematological paraneoplastic syndromes". Semin. Oncol. 24 (3): 329–33. PMID 9208888.
- ^ Zadik Y, Nitzan DW (October 2011). "Tumor induced osteomalacia: A forgotten paraneoplastic syndrome?". Oral Oncol. doi:10.1016/j.joms.2011.02.124. PMID 21985764. http://www.sciencedirect.com/science/article/pii/S1368837511008268.
- ^ Rees JH (2004). "PARANEOPLASTIC SYNDROMES: WHEN TO SUSPECT, HOW TO CONFIRM, AND HOW TO MANAGE". J. Neurol. Neurosurg. Psychiatr. 75 Suppl 2 (Suppl 2): ii43–50. doi:10.1136/jnnp.2004.040378. PMC 1765657. PMID 15146039. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1765657.
- ^ Darnell RB, Posner JB (2006). "Paraneoplastic syndromes affecting the nervous system". Semin Oncol 33 (3): 270–98. doi:10.1053/j.seminoncol.2006.03.008. PMID 16769417.
External links
- Neuroimmunology, The Medical School, Birmingham University - Paraneoplastic neurological autoantibodies, Birmingham UK
- http://www.antibodypatterns.com/hu.php
- IPA website
- Rockefeller University clinical research laboratory devoted to the paraneoplastic neurologic disorders
Pathology: Tumor, Neoplasm, Cancer, and Oncology (C00–D48, 140–239) Conditions Malignant progressionTopographyHead/Neck (Oral, Nasopharyngeal) · Digestive system · Respiratory system · Bone · Skin · Blood · Urogenital · Nervous system · Endocrine systemHistologyOtherPrecancerous condition · Paraneoplastic syndromeStaging/grading Carcinogenesis Misc. M: NEO
tsoc, mrkr
tumr, epon, para
drug (L1i/1e/V03)
Paraneoplastic syndromes Endocrine Hematological Neurological Paraneoplastic cerebellar degeneration · Encephalomyelitis · Limbic encephalitis · Opsoclonus · Polymyositis · Transverse myelitis · Lambert–Eaton myasthenic syndrome · Anti-NMDA receptor encephalitisMusculoskeletal Dermatomyositis · Hypertrophic osteoarthropathyMucocutaneous reactive erythema: Erythema gyratum repens · Necrolytic migratory erythema
papulosquamous: Acanthosis nigricans · Acquired ichthyosis · Acrokeratosis paraneoplastica of Bazex · Extramammary Paget's disease · Florid cutaneous papillomatosis · Leser-Trélat sign · Pityriasis rotunda · Tripe palms
other/ungrouped: Febrile neutrophilic dermatosis · Pyoderma gangrenosum · Paraneoplastic pemphigusM: NEO
tsoc, mrkr
tumr, epon, para
drug (L1i/1e/V03)
Categories:- Paraneoplastic syndromes
- Immune system disorders
Wikimedia Foundation. 2010.